De novo, heterozygous, loss-of-function mutations in SYNGAP1 cause a syndromic form of intellectual disability.
about
Phase Transition in Postsynaptic Densities Underlies Formation of Synaptic Complexes and Synaptic PlasticityPrioritizing the development of mouse models for childhood brain disordersAnalysis of 31-year-old patient with SYNGAP1 gene defect points to importance of variants in broader splice regions and reveals developmental trajectory of SYNGAP1-associated phenotype: case report.Analysis of exome data for 4293 trios suggests GPI-anchor biogenesis defects are a rare cause of developmental disorders.Emerging Synaptic Molecules as Candidates in the Etiology of Neurological Disorders.Genetic and neurodevelopmental spectrum of SYNGAP1-associated intellectual disability and epilepsy.Mutation analysis by direct and whole exome sequencing in familial and sporadic tooth agenesis.Diagnostic Targeted Resequencing in 349 Patients with Drug-Resistant Pediatric Epilepsies Identifies Causative Mutations in 30 Different Genes.Anchoring high concentrations of SynGAP at postsynaptic densities via liquid-liquid phase separation.The first international conference on SYNGAP1-related brain disorders: a stakeholder meeting of families, researchers, clinicians, and regulators.Improved Scalability of Neuron-Based Phenotypic Screening Assays for Therapeutic Discovery in Neuropsychiatric Disorders.Species-conserved SYNGAP1 phenotypes associated with neurodevelopmental disorders.Common terms for rare epilepsies: Synonyms, associated terms, and links to structured vocabularies.Genomics of autism spectrum disorder: approach to therapy.Stable transmission of an unbalanced chromosome 21 derived from chromoanasynthesis in a patient with a likely pathogenic variant
P2860
Q27727746-E468AE2A-421B-4FD9-BD7C-EBD8C856D7E8Q30366940-EA3ECBEE-05CA-46E6-91D7-8EAEB37FE58EQ33759405-A1508FDE-A5CD-40E1-AA0F-45993E4ABDEDQ33815229-883409B1-357A-498C-A5E7-A215D0C00E9AQ37694175-218325F1-0279-4955-B580-550F92E4494CQ38779251-DA88C28D-FDCB-42FB-B947-EAE0470F17D3Q38817939-E3BDC50A-AC28-4135-98E0-85FF0C8EDBE5Q39172712-A9C6EB69-8D7C-4901-972A-CF2CC37A9EE4Q48034764-C4C5A2FA-52AC-40B1-A39D-17327F851B26Q48506226-F240E957-1FB8-4151-ADB2-FB6064A4A89DQ52338579-D1733CF9-88F4-4984-9CB1-4763327CA5B5Q52629859-53DEA3C2-FF03-4F3F-9874-717BE790CF4EQ53834379-6B493254-2D52-4F03-A435-CDDA24592839Q55428386-368B6671-66B3-4F88-ABB5-565A5CE7C818Q58699052-05E62F3B-439B-4006-BA45-B8370FA9658B
P2860
De novo, heterozygous, loss-of-function mutations in SYNGAP1 cause a syndromic form of intellectual disability.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
De novo, heterozygous, loss-of ...... rm of intellectual disability.
@en
De novo, heterozygous, loss-of ...... rm of intellectual disability.
@nl
type
label
De novo, heterozygous, loss-of ...... rm of intellectual disability.
@en
De novo, heterozygous, loss-of ...... rm of intellectual disability.
@nl
prefLabel
De novo, heterozygous, loss-of ...... rm of intellectual disability.
@en
De novo, heterozygous, loss-of ...... rm of intellectual disability.
@nl
P2093
P2860
P356
P1476
De novo, heterozygous, loss-of ...... orm of intellectual disability
@en
P2093
Alan E Fryer
Alex C Magee
Damien Lederer
Deborah J Shears
Isabelle Maystadt
Michael J Parker
Pradeep C Vasudevan
Shane A McKee
Shehla Mohammed
P2860
P304
P356
10.1002/AJMG.A.37189
P407
P577
2015-06-15T00:00:00Z